About Eleven Biotherapeutics (adapted from Eleven Biotherapeutics prospectus):
They are a clinical-stage biopharmaceutical company with a proprietary protein engineering platform, called AMP-Rx, that they apply to the discovery and development of protein therapeutics to treat diseases of the eye.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.